Skip to main content
. 2019 Apr 29;14(4):e0205626. doi: 10.1371/journal.pone.0205626

Fig 5. Activation and nuclear translocation of Nrf2 in DSBA-treated BM-MNCs.

Fig 5

BM-MNCs were treated for 4h with DSBA at increasing concentrations from 5 to 20 μM and levels of Nrf2 protein and the Nrf2-dependent genes HO-1, ALDH1, and GSTP were assessed by immunoblotting in cellular extracts before (A) or after fractionation of cytosolic (B) and nuclear components (C).